Transcriptional Regulation of Angiotensinogen Gene Expression

Allan R. Brasier, Youqi Han, Christopher T. Sherman

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The renin-angiotensin system (RAS) is an extracellular hormonal system implicated in acute, homeostatic control of peripheral vascular resistance and electrolyte homeostasis. In this tightly regulated system, physiological regulators of blood pressure and fluid balance induce the production of the potent vasoactive angiotensin peptides by sequential proteolysis of the angiotensinogen (AGT) prohormone. AGT is the only known precursor of the angiotensin peptides, whose circulating concentrations influence the tonic activity of the RAS. AGT abundance is regulated at the transcriptional level through hormonal and cell-type specific regulators. In this review, we will discuss the identified mechanisms controlling AGT expression separately for the rodent and human genes. The most intensively investigated gene (rodent AGT) is regulated constitutively by multiple positive- and negative-acting cis factors that function in a cell-type dependent fashion. Inducible rodent AGT expression is mediated through a multihormone-inducible enhancer that integrates signals from steroid and cytokine hormones into AGT transcription. We review recent advances in understanding the mechanism of the nuclear factor-κB (NF-κB) family in mediating cytokine-induced AGT expression and our recent discoveries on the existence of differentially inducible pools of cytoplasmic NF-κB. Constitutive control of the human AGT gene will be discussed; there is surprisingly little information on the cis- and trans-acting regulators controlling inducible expression of human AGT. Finally, we will explore some of the recent developments in gene linkage studies where human AGT alleles have been associated with hypertensive phenotypes through a mechanism that may involve enhanced transcription. These studies have provided a molecular explanation for a subset of heritable hypertensive disorders in humans.

Original languageEnglish (US)
Pages (from-to)217-247
Number of pages31
JournalVitamins and Hormones
Volume57
Issue numberC
DOIs
StatePublished - 1997

Fingerprint

Angiotensinogen
Gene Expression Regulation
Gene expression
Angiotensins
Genes
Rodentia
Transcription
Renin-Angiotensin System
Renin
Vascular Resistance
Proteolysis
Cytokines
Peptides
Water-Electrolyte Balance
Blood pressure
Electrolytes
Homeostasis
Alleles
Steroids
Hormones

ASJC Scopus subject areas

  • Endocrinology
  • Physiology
  • Biochemistry

Cite this

Transcriptional Regulation of Angiotensinogen Gene Expression. / Brasier, Allan R.; Han, Youqi; Sherman, Christopher T.

In: Vitamins and Hormones, Vol. 57, No. C, 1997, p. 217-247.

Research output: Contribution to journalArticle

Brasier, Allan R. ; Han, Youqi ; Sherman, Christopher T. / Transcriptional Regulation of Angiotensinogen Gene Expression. In: Vitamins and Hormones. 1997 ; Vol. 57, No. C. pp. 217-247.
@article{a03da32ba5dc418785ef2ad3f7a38350,
title = "Transcriptional Regulation of Angiotensinogen Gene Expression",
abstract = "The renin-angiotensin system (RAS) is an extracellular hormonal system implicated in acute, homeostatic control of peripheral vascular resistance and electrolyte homeostasis. In this tightly regulated system, physiological regulators of blood pressure and fluid balance induce the production of the potent vasoactive angiotensin peptides by sequential proteolysis of the angiotensinogen (AGT) prohormone. AGT is the only known precursor of the angiotensin peptides, whose circulating concentrations influence the tonic activity of the RAS. AGT abundance is regulated at the transcriptional level through hormonal and cell-type specific regulators. In this review, we will discuss the identified mechanisms controlling AGT expression separately for the rodent and human genes. The most intensively investigated gene (rodent AGT) is regulated constitutively by multiple positive- and negative-acting cis factors that function in a cell-type dependent fashion. Inducible rodent AGT expression is mediated through a multihormone-inducible enhancer that integrates signals from steroid and cytokine hormones into AGT transcription. We review recent advances in understanding the mechanism of the nuclear factor-κB (NF-κB) family in mediating cytokine-induced AGT expression and our recent discoveries on the existence of differentially inducible pools of cytoplasmic NF-κB. Constitutive control of the human AGT gene will be discussed; there is surprisingly little information on the cis- and trans-acting regulators controlling inducible expression of human AGT. Finally, we will explore some of the recent developments in gene linkage studies where human AGT alleles have been associated with hypertensive phenotypes through a mechanism that may involve enhanced transcription. These studies have provided a molecular explanation for a subset of heritable hypertensive disorders in humans.",
author = "Brasier, {Allan R.} and Youqi Han and Sherman, {Christopher T.}",
year = "1997",
doi = "10.1016/S0083-6729(08)60645-7",
language = "English (US)",
volume = "57",
pages = "217--247",
journal = "Vitamins and Hormones",
issn = "0083-6729",
publisher = "Academic Press Inc.",
number = "C",

}

TY - JOUR

T1 - Transcriptional Regulation of Angiotensinogen Gene Expression

AU - Brasier, Allan R.

AU - Han, Youqi

AU - Sherman, Christopher T.

PY - 1997

Y1 - 1997

N2 - The renin-angiotensin system (RAS) is an extracellular hormonal system implicated in acute, homeostatic control of peripheral vascular resistance and electrolyte homeostasis. In this tightly regulated system, physiological regulators of blood pressure and fluid balance induce the production of the potent vasoactive angiotensin peptides by sequential proteolysis of the angiotensinogen (AGT) prohormone. AGT is the only known precursor of the angiotensin peptides, whose circulating concentrations influence the tonic activity of the RAS. AGT abundance is regulated at the transcriptional level through hormonal and cell-type specific regulators. In this review, we will discuss the identified mechanisms controlling AGT expression separately for the rodent and human genes. The most intensively investigated gene (rodent AGT) is regulated constitutively by multiple positive- and negative-acting cis factors that function in a cell-type dependent fashion. Inducible rodent AGT expression is mediated through a multihormone-inducible enhancer that integrates signals from steroid and cytokine hormones into AGT transcription. We review recent advances in understanding the mechanism of the nuclear factor-κB (NF-κB) family in mediating cytokine-induced AGT expression and our recent discoveries on the existence of differentially inducible pools of cytoplasmic NF-κB. Constitutive control of the human AGT gene will be discussed; there is surprisingly little information on the cis- and trans-acting regulators controlling inducible expression of human AGT. Finally, we will explore some of the recent developments in gene linkage studies where human AGT alleles have been associated with hypertensive phenotypes through a mechanism that may involve enhanced transcription. These studies have provided a molecular explanation for a subset of heritable hypertensive disorders in humans.

AB - The renin-angiotensin system (RAS) is an extracellular hormonal system implicated in acute, homeostatic control of peripheral vascular resistance and electrolyte homeostasis. In this tightly regulated system, physiological regulators of blood pressure and fluid balance induce the production of the potent vasoactive angiotensin peptides by sequential proteolysis of the angiotensinogen (AGT) prohormone. AGT is the only known precursor of the angiotensin peptides, whose circulating concentrations influence the tonic activity of the RAS. AGT abundance is regulated at the transcriptional level through hormonal and cell-type specific regulators. In this review, we will discuss the identified mechanisms controlling AGT expression separately for the rodent and human genes. The most intensively investigated gene (rodent AGT) is regulated constitutively by multiple positive- and negative-acting cis factors that function in a cell-type dependent fashion. Inducible rodent AGT expression is mediated through a multihormone-inducible enhancer that integrates signals from steroid and cytokine hormones into AGT transcription. We review recent advances in understanding the mechanism of the nuclear factor-κB (NF-κB) family in mediating cytokine-induced AGT expression and our recent discoveries on the existence of differentially inducible pools of cytoplasmic NF-κB. Constitutive control of the human AGT gene will be discussed; there is surprisingly little information on the cis- and trans-acting regulators controlling inducible expression of human AGT. Finally, we will explore some of the recent developments in gene linkage studies where human AGT alleles have been associated with hypertensive phenotypes through a mechanism that may involve enhanced transcription. These studies have provided a molecular explanation for a subset of heritable hypertensive disorders in humans.

UR - http://www.scopus.com/inward/record.url?scp=0032601983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032601983&partnerID=8YFLogxK

U2 - 10.1016/S0083-6729(08)60645-7

DO - 10.1016/S0083-6729(08)60645-7

M3 - Article

C2 - 10232051

AN - SCOPUS:0032601983

VL - 57

SP - 217

EP - 247

JO - Vitamins and Hormones

JF - Vitamins and Hormones

SN - 0083-6729

IS - C

ER -